It is day five. The patient calls, or messages a photograph, and one brow is clearly sitting higher than the other. Every instinct says to get her in and put a couple of units where they are needed. The botox two-week rule exists to stop you doing that, and Dr. Chris Croley teaches it as a standing constraint on re-intervention: "We know that neurotoxin can continue to set in and continue to impact muscles for up to two weeks after administration. So we usually don't do any corrective action within those first two weeks."
This piece is about clinician timing — when it is appropriate to put a needle back into a face you have already treated. It is not post-treatment patient instruction. If you need patient-facing guidance to hand out, that is a separate conversation with a different audience.
The rule and the reason behind it
Neurotoxin effect is not a step function. It develops. The clinical picture at day three, day five and day fourteen are three different pictures of the same treatment, and only the last one is the treatment.
Dr. Croley is specific about this when he presents the case he teaches from. The patient is being assessed three weeks after her prior cosmetic toxin, and he flags the interval deliberately: "This was three weeks after prior cosmetic toxin. So keep in mind, this is not three days later."
That aside is the teaching point. A complication assessed at three days is not yet a complication. It is an incomplete treatment being read as a finished one.
Three ways an early assessment misleads you
Understanding how you get fooled is more useful than memorising the number.
The asymmetry may still be closing. If two deposits are developing at different rates — and they routinely do — the lagging side may still be coming on. A day-five asymmetry can be a timing difference rather than a dose difference. Wait, and the two sides converge. Inject, and you have permanently separated them.
What looks like too much may settle. A brow that reads as over-treated at day four may look appropriate at day fourteen as the effect distributes and the patient's recruitment pattern adapts. Early over-reading leads to corrective doses aimed at a problem that was about to resolve on its own.
Gradients develop unevenly. In a continuous sheet like the frontalis, the effect is a field, not a set of points, and that field takes time to establish across the muscle. Apparent brow asymmetry in the first week is very often a gradient that has not finished forming. This is one of the reasons frontalis work is the single most common source of premature correction — the frontalis dosing discussion covers the dose side of the same region.
The stacking problem
Beyond misreading the picture, early re-injection creates a second and more serious problem: you are dosing against a moving target.
At day five, you do not know the final effect of the dose already in the tissue. If you add units now, you are adding a known dose to an unknown one, and the two will reach their combined peak together somewhere around day twelve to fourteen. The result is not the correction you intended. It is the correction plus whatever the original dose had left to deliver.
That overshoot is the mechanism that converts an asymmetry into the opposite asymmetry, and it lasts longer, because the more units reach a muscle, the longer that muscle stays weak. You have entered the chasing loop through the front door, on day five, before there was even a confirmed problem.
There is a documentation consequence too. If you inject at day five and the outcome at day fourteen is poor, you can no longer attribute cause. You do not know whether the original plan was wrong, the correction was wrong, or the sum was wrong — which means you learn nothing and cannot plan the next treatment cycle intelligently.
What you actually do between day zero and day fourteen
Waiting is not the same as ignoring, and the difference matters clinically and commercially. Do all of this.
Take the call and respond quickly. A patient who cannot reach you on day five will conclude that something has gone badly wrong and that you are avoiding her. Speed of response and speed of intervention are different things.
Bring her in — as an assessment visit, not a treatment visit. Say so explicitly when you book it: "I want to see you and photograph this, and I'm not going to inject anything today. Here's why." Setting that frame before she arrives prevents the visit becoming a negotiation.
Photograph properly, at rest and with animation. Dr. Croley's assessment sequence is "we observe the patient at rest, and with animation, we diagnose the problem." Both are required, because at rest the finding may be genuinely subtle — in the case he teaches from, "the right face appears slightly flatter, the left oral commissure is slightly higher, but those are subtle changes. This is not something that the patient may even notice." His conclusion is that "your clinical decision then has to be based on their dynamic movements." A record made only at rest will not support the decision you make later.
Explain the developmental timeline. Tell her the effect is still setting in, that the picture will change over the next week or more, and that acting now risks creating a problem that is harder to undo than the one she has. Most patients accept this readily when they hear the reason.
Book the review before she leaves. Day fourteen or later, in the diary, with photographs to compare against. An open-ended "call me if it's still bothering you" leaves the patient managing the timeline, and she will call on day eight.
Write down the original plan. Muscles, units, distribution. If you are going to reason about the day-fourteen picture, you need the day-zero inputs.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Aesthetic & Injectable Training courses — live patients, expert faculty, and ongoing mentorship.
Where the rule does not apply
The two-week rule governs elective corrective injection for an aesthetic asymmetry. It is not a general instruction to wait two weeks about anything that happens after a treatment.
Anything suggesting infection, a vascular event, or a functional problem affecting vision, swallowing or breathing is a different pathway entirely and is assessed and managed on its own timeline, immediately. Do not let a rule about touch-up timing delay evaluation of a problem that is not a touch-up problem. If there is any doubt about which category you are in, the patient is seen.
The other situation worth naming is the patient with a fixed event inside the two weeks. Dr. Croley discusses this directly in the context of goal-setting — the patient "scheduled for a big photo shoot" who needs symmetry more than she needs movement. That is a real consideration, but be clear-eyed about what the event does and does not change. It does not reduce the uncertainty. The toxin is still setting in and you still cannot see the endpoint. What the event changes is who bears the risk and whether they accept it.
If you do treat inside the window because of a genuine deadline, then the dose should be smaller than it would be at day fourteen, not larger; the decision and its rationale should be documented; and the patient should understand explicitly that the result may overshoot as the original dose completes. That kind of specific, named risk is exactly what belongs in your consent documentation.
Two weeks is also the interval after a correction
The rule is not only a gate before the first corrective injection. It is the reassessment interval after every one.
Dr. Croley's correction sequence ends with it: "Start conservatively, using low doses of our neurotoxin, place it according to muscle size, strength, the role of the risk — and then reassess the patient in two weeks."
This matters because the corrective dose obeys the same pharmacology as the original. It also takes up to two weeks to declare itself. A clinician who corrects at day fourteen and then corrects the correction at day nineteen has reintroduced the exact error the rule was written to prevent, and is now stacking three overlapping effects in one face.
One correction. Fourteen days. Reassess. That cadence, held consistently, is what keeps a complication a single event rather than a quarter-long project.
What changes on Monday
Put the rule in your booking system, not just in your head. Any request to be seen about an asymmetry inside fourteen days is booked as a review appointment with a note that no injection is planned. Making it a process decision removes it from being a judgement call under pressure.
Write the timeline into your post-treatment communication. A line saying the effect continues to develop for up to two weeks, and that any adjustment is assessed after that, means the day-five call often does not happen at all — and when it does, you are reminding rather than explaining.
Standardise your photography. Same position, same lighting, at rest and with full animation. Comparing a day-five phone snapshot to a day-fourteen clinic photograph is not a comparison.
Hold the line on the second correction as firmly as the first. The temptation to adjust at day five is obvious. The temptation to adjust a correction at day five is easier to rationalise and does more damage.
This approach reflects Dr. Chris Croley's clinical practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.
Timing decisions like this sit alongside dose selection and anatomy as the practical content of neurotoxin practice. Empire covers them in Complete Botox Training and Cosmetic Neurotoxins Training.
Frequently Asked Questions
Why wait two weeks before correcting a neurotoxin asymmetry?
Because the effect is still developing. Dr. Croley teaches that neurotoxin can continue to set in and affect muscles for up to two weeks after administration, so an asymmetry seen at day five may still resolve on its own. Injecting before day fourteen adds a known dose to an unknown one and commonly overshoots.
What do I tell a patient who calls on day five?
Explain that the effect is still setting in and the picture will change, offer an assessment visit for photographs at rest and with animation, and book a review at day fourteen or later. Respond quickly — the speed of your response and the speed of intervention are different things, and patients read silence as avoidance.
Are there situations where I should act before two weeks?
Yes, but not for elective aesthetic asymmetry. Anything suggesting infection, a vascular event, or a functional problem affecting vision, swallowing or breathing is assessed immediately on its own pathway. A patient with a fixed event inside the window is a judgement call: the uncertainty is unchanged, the dose should be smaller, and the reasoning should be documented.
Does the two-week rule apply after a corrective injection as well?
Yes. The corrective dose follows the same pharmacology and also takes up to two weeks to declare itself. Dr. Croley's sequence ends with reassessing the patient at two weeks. Correcting a correction inside that window stacks three overlapping effects in one face and is how a single complication becomes a months-long problem.
Disclaimer
This article reflects the clinical opinions and experience of Dr. Chris Croley, Chief Medical Officer, Empire Medical Training, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.
It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.
